Adjuncts for maximizing resection: 5-Aminolevuinic acid

Clinical Neurosurgery

Volumn 59, Issue , 2012, Pages 75-78

  Roberts, David W ^a   Valdés, Pablo A ^a   Harris, Brent T ^b   Hartov, Alexander ^c   Fan, Xiaoyao ^c   Ji, Songbai ^c   Pogue, Brian W ^c   Leblond, Frederic ^c   Tosteson, Tor D ^a   Wilson, Brian C ^d   Paulsen, Keith D ^c  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c DARTMOUTH COLLEGE   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINOLEVUINIC ACID; AMINOLEVULINIC ACID; PROTOPORPHYRIN; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; PHOTOSENSITIZING AGENT;

ARTICLE; CANCER SURGERY; FLUORESCENCE; GLIOMA; HISTOPATHOLOGY; PRIORITY JOURNAL; BRAIN TUMOR; HUMAN; METHODOLOGY; NEUROSURGERY; PEROPERATIVE CARE; REVIEW;

AMINOLEVULINIC ACID; BRAIN NEOPLASMS; GLIOMA; HUMANS; INTRAOPERATIVE CARE; NEUROSURGICAL PROCEDURES; PHOTOSENSITIZING AGENTS;

EID: 84868235564     PISSN: 00694827     EISSN: 0148396X     Source Type: Journal    
DOI: 10.1227/NEU.0b013e31826b2e8b     Document Type: Article

References (14)

1. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006;7(5):392-401.
2. Pichlmeier U, Bink A, Schackert G, Stummer W. Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol. 2008;10(6):1025-1034.
3. Stummer W, Nestler U, Stockhammer F, et al. Favorable outcome in the elderly cohort treated by concomitant temozolomide radiochemotherapy in a multicentric phase II safety study of 5-ALA. J Neurooncol. 2011;103(2):361-370.
4. Hayashi Y, Nakada M, Tanaka S, et al. Implication of 5-aminolevulinic acid fluorescence of the ventricular wall for postoperative communicating hydrocephalus associated with cerebrospinal fluid dissemination in patients with glioblastoma multiforme: a report of 7 cases. J Neurosurg. 2010;112(5):1015- 1019.
5. Hefti M, Von Campe G, Moschopulos M, Siegner A, Looser H, Landolt H. 5-Aminolevulinic acid induced protoporphyrin IX fluorescence in high-grade glioma surgery: a one-year experience at a single institution. Swiss Med Wkly. 2008;138(11-12):180-185.
6. Ritz R, Feigl GC, Schuhmann MU, et al. Use of 5-ALA fluorescence guided endoscopic biopsy of a deep-seated primary malignant brain tumor. J Neurosurg. 2011;114(5):1410-1413.
7. Tamura Y, Kuroiwa T, Kajimoto Y, Miki Y, Miyatake S, Tsuji M. Endoscopic identification and biopsy sampling of an intraventricular malignant glioma using a 5-aminolevulinic acid-induced protoporphyrin IX fluorescence imaging system: technical note. J Neurosurg. 2007;106(3):507-510. (Pubitemid 46354309)
8. Widhalm G, Wolfsberger S, Minchev G, et al. 5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement. Cancer. 2010;116(6):1545-1552.
9. Roberts DW, Valdes PA, Harris BT, et al. Coregistered fluorescenceenhanced tumor resection of malignant glioma: relationships between delta-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters: clinical article. J Neurosurg. 2011;114(3):595-603.
10. Valdés PA, Leblond F, Kim A, et al. Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. J Neurosurg. 2011;115(1):11-17.
11. Valdés PA, Fan X, Ji S, Harris BT, Paulsen KD, Roberts DW. Estimation of brain deformation for volumetric image updating in protoporphyrin IX fluorescence-guided resection. Stereotact Funct Neurosurg. 2010;88(1):1-10.
12. Valdés PA, Kim A, Leblond F, et al. Combined fluorescence and reflectance spectroscopy for in vivo quantification of cancer biomarkers in low-and high-grade glioma surgery. J Biomed Opt. 2011;16(11):116007.
13. Valdés PA, Kim A, Brantsch M, et al. Delta-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescenceguided resection to identify regions of increasing malignancy. Neuro Oncol. 2011;13(8):846-856.
14. Stummer W, Tonn JC, Mehdorn HM, et al. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study: clinical article. J Neurosurg. 2011;114(3):613-623.